Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12575592 | Method for producing biomimetic nutrient mixture via biomimicry | 🖼🧊📄§ | 2026-03-17 | 2042-11-09 | 0 | 31 |
| 12575735 | Devices, systems, and methods for tumor visualization and removal | 🖼🧊📄§ | 2026-03-17 | 2040-01-17 | 0 | 31 |
| 12576031 | Magnetic wire for retrieval and elimination of calculus from the urinary tract | 🖼🧊📄§ | 2026-03-17 | 2043-12-27 | 0 | 31 |
| 12576013 | Dissolvable solid fibrous shampoo articles containing salts | 🖼🧊📄§ | 2026-03-17 | 2042-12-14 | 0 | 31 |
| 12576036 | Marine organism infused effervescent tablet for producing enhanced suspensions | 🖼🧊📄§ | 2026-03-17 | 2045-09-10 | 0 | 31 |
| 12576033 | Spray-dried formulation of a pyridazinone TRPC5 inhibitor | 🖼🧊📄§ | 2026-03-17 | 2040-04-10 | 0 | 31 |
| 12576017 | Sunscreen composition with enhanced photoprotection | 🖼🧊📄§ | 2026-03-17 | 2041-09-23 | 0 | 31 |
| 12576023 | Fermented nano-emulsifier composition and preparation method therefor | 🖼🧊📄§ | 2026-03-17 | 2041-05-24 | 0 | 31 |
| 12576043 | Xanthophyll composition comprising lutein and zeaxanthin with enhanced bioavailability | 🖼🧊📄§ | 2026-03-17 | 2040-10-10 | 0 | 31 |
| 12576114 | Methods of functional vascularization of pancreatic islets and beta-cell organoids | 🖼🧊📄§ | 2026-03-17 | 2040-07-02 | 0 | 31 |
| 12576143 | Teleost invariant chain cancer vaccine | 🖼🧊📄§ | 2026-03-17 | 2039-10-18 | 0 | 31 |
| 12577285 | Process for producing a composition of engineered T cells | 🖼🧊📄§ | 2026-03-17 | 2038-12-07 | 0 | 31 |
| 12576015 | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an alcohol compound, and cosmetic composition containing same | 🖼🧊📄§ | 2026-03-17 | 2039-12-17 | 0 | 31 |
| 12577255 | MDM2-based modulators of proteolysis and associated methods of use | 🖼🧊📄§ | 2026-03-17 | 2042-01-06 | 0 | 31 |
| 12577312 | Methods for the treatment of melanoma using compositions of denosumab and PD-1 inhibitor | 🖼🧊📄§ | 2026-03-17 | 2045-02-26 | 0 | 31 |
| 12580049 | Tumor microenvironment-based methods for assessing CAR-T and other immunotherapies | 🖼🧊📄§ | 2026-03-17 | 2042-12-23 | 0 | 31 |
| 12576119 | Bacteriophage compositions and methods for treatment of bacterial infections | 🖼🧊📄§ | 2026-03-17 | 2045-04-14 | 0 | 31 |
| 12576138 | Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase | 🖼🧊📄§ | 2026-03-17 | 2039-05-17 | 0 | 31 |
| 12577283 | Knockdown or knockout of one or more of TAP2, NLRC5, B2m, TRAC, RFX5, RFXAP and RFXANK to mitigate t cell recognition of allogeneic cell products | 🖼🧊📄§ | 2026-03-17 | 2042-01-28 | 0 | 31 |
| 12577325 | Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereof | 🖼🧊📄§ | 2026-03-17 | 2044-11-22 | 0 | 31 |
| 12577222 | Phenethylamine compounds salts, polymorphic forms and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2044-01-19 | 0 | 31 |
| 12576129 | Anthelmintic compositions and methods | 🖼🧊📄§ | 2026-03-17 | 2042-09-23 | 0 | 31 |
| 12576057 | Antibacterial and biofilm formation-inhibiting composition containing myristoleic acid as active ingredient | 🖼🧊📄§ | 2026-03-17 | 2042-11-18 | 0 | 31 |
| 12576149 | Gamma delta T cells derived from induced pluripotent stem cells, and production method therefor | 🖼🧊📄§ | 2026-03-17 | 2045-01-14 | 0 | 31 |
| 12576053 | Use of 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl) methylidenejinden-1-yl] acetic acid | 🖼🧊📄§ | 2026-03-17 | 2038-04-11 | 0 | 31 |
| 12576058 | Methods for decreasing injuries associated with intraoperative hypotension | 🖼🧊📄§ | 2026-03-17 | 2044-04-30 | 0 | 31 |
| 12576123 | Epitope-based approach for allergy treatments and inhibitors for Crohn's disease | 🖼🧊📄§ | 2026-03-17 | 2040-03-13 | 0 | 31 |
| 12576154 | Conjugates of PSMA-binding moieties with cytotoxic agents | 🖼🧊📄§ | 2026-03-17 | 2043-07-31 | 0 | 31 |
| 12576062 | Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs | 🖼🧊📄§ | 2026-03-17 | 2040-03-17 | 0 | 31 |
| 12576118 | Bacteriophages for the treatment of tuberculosis | 🖼🧊📄§ | 2026-03-17 | 2040-05-21 | 0 | 31 |
| 12576045 | Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia | 🖼🧊📄§ | 2026-03-17 | 2043-02-06 | 0 | 31 |
| 12576166 | Contrast agents for detection of enzyme activities based on melanin synthesis | 🖼🧊📄§ | 2026-03-17 | 2041-07-26 | 0 | 31 |
| 12576158 | Antibody drug conjugates with cleavable linkers | 🖼🧊📄§ | 2026-03-17 | 2040-05-22 | 0 | 31 |
| 12576040 | Ionizable lipids and methods of manufacture and use thereof | 🖼🧊📄§ | 2026-03-17 | 2041-10-13 | 0 | 31 |
| 12576140 | Cyclophilin 40 for reduction of neurotoxic fibrils and treatment of neurodegenerative diseases | 🖼🧊📄§ | 2026-03-17 | 2041-07-29 | 0 | 31 |
| 12576133 | Antigen-binding agents that specifically bind epidermal growth factor receptor variant III | 🖼🧊📄§ | 2026-03-17 | 2040-03-23 | 0 | 31 |
| 12576083 | Combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer | 🖼🧊📄§ | 2026-03-17 | 2044-01-17 | 0 | 31 |
| 12576094 | Combination cannabinoid-phenylethanoid formulation for treatment of inflammation and methods related thereto | 🖼🧊📄§ | 2026-03-17 | 2040-11-20 | 0 | 31 |
| 12576077 | Composition for preventing, alleviating or treating cancer | 🖼🧊📄§ | 2026-03-17 | 2043-08-28 | 0 | 31 |
| 12576068 | Compositions containing amino acids and methods of using such compositions for treating sarcopenia | 🖼🧊📄§ | 2026-03-17 | 2041-04-01 | 0 | 31 |
| 12576104 | Dental preparation comprising fibers based on hyaluronic acid with regulated biodegradability | 🖼🧊📄§ | 2026-03-17 | 2041-01-05 | 0 | 31 |
| 12577292 | Ferritin nanocage for multi-displaying trail trimer and cancer-targeting peptide and use thereof as anticancer agent | 🖼🧊📄§ | 2026-03-17 | 2040-03-06 | 0 | 31 |
| 12577254 | Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors | 🖼🧊📄§ | 2026-03-17 | 2043-08-18 | 0 | 31 |
| 12576121 | Acacia nilotica based hydrogel and method of making the same | 🖼🧊📄§ | 2026-03-17 | 2045-12-12 | 0 | 31 |
| 12577316 | Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies | 🖼🧊📄§ | 2026-03-17 | 2043-10-27 | 0 | 31 |
| 12577287 | T cell receptors and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-03-24 | 0 | 31 |
| 12577324 | Antibodies having specificity to HER4 and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2040-12-08 | 0 | 31 |
| 12576093 | Pharmaceutical composition for subcutaneous administration | 🖼🧊📄§ | 2026-03-17 | 2040-07-15 | 0 | 31 |
| 12576212 | Medicine injection and disease management systems, devices, and methods | 🖼🧊📄§ | 2026-03-17 | 2042-07-11 | 0 | 31 |
| 12577238 | Compositions and methods for modulating inflammatory and degenerative disorder | 🖼🧊📄§ | 2026-03-17 | 2042-08-17 | 0 | 31 |